"Designing Growth Strategies is in our DNA"

Autism Spectrum Disorder Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Therapy (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors, Stimulants, Sleep Medications, and Others), By Disease (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), By Age Group (Children and Adults), By Distribution Channel (Hospital Pharmacies, Drugs Stores & Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI101207

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Autism Spectrum Disorder– Key Countries/ Regions
    2. Key Industry Developments (Mergers, Acquisition and Partnerships)
    3. Pipeline Analysis
    4. Economic Cost Burden for the Treatment of Autism Spectrum Disorder
    5. Regulatory and Reimbursement Scenario– Key Countries/ Regions
    6. Research and Development Analysis
    7. Impact of Covid-19 on the Market
  5. Global Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030 
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East and Africa
  6. North America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Disease
      2. Canada
        1. By Disease
  7. Europe Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By County/ Sub-region
      1. U.K
        1. By Disease
      2. Germany
        1. By Disease
      3. France
        1. By Disease
      4. Italy
        1. By Disease
      5. Spain
        1. By Disease
      6. Scandinavia
        1. By Disease
      7. Rest of Europe
        1. By Disease
  8. Asia Pacific Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. China
        1. By Disease
      2. Japan
        1. By Disease
      3. India
        1. By Disease
      4. Australia
        1. By Disease
      5. Southeast Asia
        1. By Disease
      6. Rest of Asia Pacific
        1. By Disease
  9. Latin America Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Brazil
        1. By Disease
      2. Mexico
        1. By Disease
      3. Rest of Latin America
        1. By Disease
  10. Middle East and Africa Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. GCC
        1. By Disease
      2. South Africa
        1. By Disease
      3. Rest of Middle East and Africa
        1. By Disease
  11. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Curemark, LLC
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Alembic Pharmaceuticals Limited.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Yamo Pharmaceuticals
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. PaxMedica
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Aurobindo Pharma Limited
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Otsuka Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. H. Lundbeck A/S
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      11. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 01: Global Autism Spectrum Disorder Therapeutics Market Value Share (%), By Drug Therapy, 2022 & 2030

Figure 02: Global Autism Spectrum Disorder Therapeutics Market Value Share (%), By Disease, 2022 & 2030

Figure 03: Global Autism Spectrum Disorder Therapeutics Market Value Share (%), By Age Group, 2022 & 2030

Figure 04: Global Autism Spectrum Disorder Therapeutics Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 05: Global Autism Spectrum Disorder Therapeutics Market Value Share (%), by Region, 2022 & 2030

Figure 06: North America Autism Spectrum Disorder Therapeutics Market Value (USD billion), By Drug Therapy, 2022 & 2030

Figure 07: North America Autism Spectrum Disorder Therapeutics Market Value Share (%), By Drug Therapy, 2022

Figure 08: North America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Disease, 2022 & 2030

Figure 09: North America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Disease, 2022

Figure 10: North America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Age Group, 2022 & 2030

Figure 11: North America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Age Group, 2022

Figure 12: North America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 13: North America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 14: North America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Country, 2022 & 2030

Figure 15: North America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Country, 2022

Figure 16: Europe Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Drug Therapy, 2022 & 2030

Figure 17: Europe Autism Spectrum Disorder Therapeutics Market Value Share (%), by Drug Therapy, 2022

Figure 18: Europe Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Disease, 2022 & 2030

Figure 19: Europe Autism Spectrum Disorder Therapeutics Market Value Share (%), by Disease, 2022

Figure 20: Europe Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Age Group, 2022 & 2030

Figure 21: Europe Autism Spectrum Disorder Therapeutics Market Value Share (%), by Age Group, 2022

Figure 22: Europe Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 23: Europe Autism Spectrum Disorder Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 24: Europe Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 25: Europe Autism Spectrum Disorder Therapeutics Market Value Share (%), by Country/Sub-Region, 2022

Figure 26: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Drug Therapy, 2022 & 2030

Figure 27: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value Share (%), by Drug Therapy, 2022

Figure 28: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Disease, 2022 & 2030

Figure 29: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value Share (%), by Disease, 2022

Figure 30: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Age Group, 2022 & 2030

Figure 31: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value Share (%), by Age Group, 2022

Figure 32: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 33: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 34: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 35: Asia Pacific Autism Spectrum Disorder Therapeutics Market Value Share (%), by Country/Sub-Region, 2022

Figure 36: Latin America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Drug Therapy, 2022 & 2030

Figure 37: Latin America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Drug Therapy, 2022

Figure 38: Latin America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Disease, 2022 & 2030

Figure 39: Latin America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Disease, 2022

Figure 40: Latin America Autism Spectrum Disorder Therapeutics Market Value (USD billion),, by Age Group, 2022 & 2030

Figure 41: Latin America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Age Group, 2022

Figure 42: Latin America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 43: Europe Autism Spectrum Disorder Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 44: Latin America Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 45: Latin America Autism Spectrum Disorder Therapeutics Market Value Share (%), by Country/Sub-Region, 2022

Figure 46: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Drug Therapy, 2022 & 2030

Figure 47: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value Share (%), 2022

Figure 48: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value (USD billion), 2022 & 2030

Figure 49: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value Share (%), 2022

Figure 50: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Age Group, 2022 & 2030

Figure 51: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value Share (%), by Age Group, 2022

Figure 52: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 53: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 54: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value (USD billion), by Country/Sub-Region, 2022 & 2030

Figure 55: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Value Share (%), by Country/Sub-Region, 2022

Table 01: Global Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Drug Therapy, 2019–2030

Table 02: Global Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 03: Global Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 04: Global Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 05: Global Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Region, 2019–2030

Table 06: North America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Drug Therapy, 2019–2030

Table 07: North America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 08: North America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 09: North America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 10: North America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Country, 2019–2030

Table 11: U.S. Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 12: Canada Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 13: Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Drug Therapy, 2019–2030

Table 14: Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 15: Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 16: Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 17: Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019–2030

Table 18: Germany Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 19: U.K. Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 20: France Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 21: Italy Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 22: Spain Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 23: Scandinavia Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 24: Rest of Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 25: Asia Pacific Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Drug Therapy, 2019–2030

Table 26: Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 27: Asia Pacific Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 28: Asia Pacific Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

Table 29: Asia Pacific Autism Spectrum Disorder Therapeutics Revenue (USD billion) Forecast, by Country/Sub-Region, 2019–2030

Table 30: China Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 31: India of Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 32: Japan of Europe Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 33: Australia Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 34: Southeast Asia Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 35: Rest of Asia Pacific Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 36: Latin America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Drug Therapy, 2019–2030

Table 37: Latin America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Disease, 2019–2030

Table 38: Latin America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 39: Latin America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Table 40: Latin America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Country, 2019–2030

Table 41: Brazil Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 42: Mexico Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 43: Rest of Latin America Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 44: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Drug Therapy, 2019–2030

Table 45: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 46: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 47: Middle East and Africa Services Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

Table 48: Middle East and Africa Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019–2030

Table 49: South Africa Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 50: GCC Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 51: Rest of Middle East & Africa Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

  • 2019-2030
  • 2022
  • 2019-2021
  • 162
Consulting Services
    How will you benefit from our consulting services ?